Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C13H18Cl2N2O2 |
Molecular Weight | 305.2 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O
InChI
InChIKey=SGDBTWWWUNNDEQ-LBPRGKRZSA-N
InChI=1S/C13H18Cl2N2O2/c14-5-7-17(8-6-15)11-3-1-10(2-4-11)9-12(16)13(18)19/h1-4,12H,5-9,16H2,(H,18,19)/t12-/m0/s1
Molecular Formula | C13H18Cl2N2O2 |
Molecular Weight | 305.2 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:16:41 UTC 2023
by
admin
on
Fri Dec 15 16:16:41 UTC 2023
|
Record UNII |
Q41OR9510P
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
485515
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
||
|
NDF-RT |
N0000000236
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
||
|
NCI_THESAURUS |
C697
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
||
|
FDA ORPHAN DRUG |
64291
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
||
|
WHO-ATC |
L01AA03
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
||
|
NDF-RT |
N0000175558
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
||
|
WHO-VATC |
QL01AA03
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
||
|
FDA ORPHAN DRUG |
60991
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
||
|
FDA ORPHAN DRUG |
378112
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
||
|
FDA ORPHAN DRUG |
270008
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
||
|
LIVERTOX |
NBK548280
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
||
|
FDA ORPHAN DRUG |
381412
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
460612
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
PRIMARY | |||
|
D008558
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
PRIMARY | |||
|
SUB08728MIG
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
PRIMARY | |||
|
6718
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
PRIMARY | RxNorm | ||
|
MELPHALAN
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
PRIMARY | |||
|
148-82-3
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
PRIMARY | |||
|
DB01042
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
PRIMARY | |||
|
C633
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
PRIMARY | |||
|
Q41OR9510P
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
PRIMARY | |||
|
241286
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
PRIMARY | |||
|
100000091410
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
PRIMARY | |||
|
28876
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
PRIMARY | |||
|
7620
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
PRIMARY | |||
|
205-726-3
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
PRIMARY | |||
|
DTXSID6020804
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
PRIMARY | |||
|
8806
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
PRIMARY | |||
|
1678
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
PRIMARY | |||
|
m7166
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
PRIMARY | Merck Index | ||
|
Q41OR9510P
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
PRIMARY | |||
|
3234
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
PRIMARY | |||
|
CHEMBL852
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
PRIMARY | |||
|
745
Created by
admin on Fri Dec 15 16:16:41 UTC 2023 , Edited by admin on Fri Dec 15 16:16:41 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
|
||
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
PRODRUG -> METABOLITE ACTIVE | |||
|
METABOLITE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (GC)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
Elimination PHARMACOKINETIC PHARMACOKINETIC |
|
||
Tmax | PHARMACOKINETIC |
|
|
|||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||